These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of haem arginate therapy on porphyrin metabolism and mixed function oxygenase activity in acute hepatic porphyria. Herrick A; McColl KE; McLellan A; Moore MR; Brodie MJ; Goldberg A Lancet; 1987 Nov; 2(8569):1178-9. PubMed ID: 2890809 [TBL] [Abstract][Full Text] [Related]
5. Controlled trial of haem arginate in acute hepatic porphyria. Herrick AL; McColl KE; Moore MR; Cook A; Goldberg A Lancet; 1989 Jun; 1(8650):1295-7. PubMed ID: 2566827 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of acute intermittent porphyria. The first use of Heme-arginate in Czechoslovakia]. Kordac V; Martásek P Cas Lek Cesk; 1987 Jul; 126(30):944-7. PubMed ID: 3652151 [No Abstract] [Full Text] [Related]
7. Haem arginate in the treatment of acute hepatic porphyrias. Mustajoki P; Tenhunen R; Tokola O; Gothoni G Br Med J (Clin Res Ed); 1986 Aug; 293(6546):538-9. PubMed ID: 3092906 [No Abstract] [Full Text] [Related]
8. Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration. Kordac V; Kozáková M; Martásek P Ann Med; 1989 Aug; 21(4):273-6. PubMed ID: 2551350 [TBL] [Abstract][Full Text] [Related]
9. The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats. Tokola O; Lindén IB; Tenhunen R Pharmacol Toxicol; 1987 Jul; 61(1):75-8. PubMed ID: 3628186 [TBL] [Abstract][Full Text] [Related]
11. Haem and porphyria attacks. Pierach CA Lancet; 1989 Jul; 2(8656):213-4. PubMed ID: 2568536 [No Abstract] [Full Text] [Related]
12. Heme arginate (Normosang) in the treatment of attacks of acute hepatic porphyrias. Kostrzewska E; Gregor A; Tarczyńska-Nosal S Mater Med Pol; 1991; 23(4):259-62. PubMed ID: 1842231 [TBL] [Abstract][Full Text] [Related]
14. Optical and EPR spectroscopy studies on haem arginate, a new compound used for treatment of porphyria. Sievers G; Häkli H; Luhtala J; Tenhunen R Chem Biol Interact; 1987; 63(2):105-14. PubMed ID: 2822264 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy and tolerability of a new hematin in the treatment of an acute attack of porphyria]. Fontaine B; Bakchine S; Derouesne C; Nordmann Y; Laplane D Presse Med; 1987 Feb; 16(4):177. PubMed ID: 2950457 [No Abstract] [Full Text] [Related]
17. [Acute attacks of hepatic porphyria: specific treatment with heme arginate]. Nordmann Y; Deybach JC Ann Med Interne (Paris); 1993; 144(3):165-7. PubMed ID: 8368699 [TBL] [Abstract][Full Text] [Related]
18. [Neurological complications of acute intermittent porphyria precipitated by porphyrinogenic drugs and efficiency of heme-arginate treatment]. Akopova-Larbi R; Ben Youssef TI; Gargouri A; Kraoua I; Gouider R; Gouider-Khouja N Tunis Med; 2009 Sep; 87(9):621-6. PubMed ID: 20180386 [TBL] [Abstract][Full Text] [Related]
19. Elevation of hormone-binding globulins in acute intermittent porphyria. Herrick AL; McColl KE; Wallace AM; Moore MR; Goldberg A Clin Chim Acta; 1990 Feb; 187(2):141-8. PubMed ID: 2107988 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute attacks of hepatic porphyrias with hematin]. Devars du Mayne JF Ann Med Interne (Paris); 1989; 140(2):83-5. PubMed ID: 2742265 [No Abstract] [Full Text] [Related] [Next] [New Search]